These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 22071333

  • 1. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R.
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [Abstract] [Full Text] [Related]

  • 2. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, Thabet M, Paul B, Reilly A, Gagnon S, Renaud JM, Kothary R.
    EBioMedicine; 2020 May; 55():102750. PubMed ID: 32339936
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.
    Murray LM, Beauvais A, Gibeault S, Courtney NL, Kothary R.
    Acta Neuropathol Commun; 2015 Sep 15; 3():55. PubMed ID: 26374403
    [Abstract] [Full Text] [Related]

  • 4. The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy.
    Kariya S, Mauricio R, Dai Y, Monani UR.
    Neurosci Lett; 2009 Jan 16; 449(3):246-51. PubMed ID: 19010394
    [Abstract] [Full Text] [Related]

  • 5. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
    Murray LM, Beauvais A, Bhanot K, Kothary R.
    Neurobiol Dis; 2013 Jan 16; 49():57-67. PubMed ID: 22960106
    [Abstract] [Full Text] [Related]

  • 6. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
    Kim JK, Caine C, Awano T, Herbst R, Monani UR.
    Hum Mol Genet; 2017 Jul 01; 26(13):2377-2385. PubMed ID: 28379354
    [Abstract] [Full Text] [Related]

  • 7. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, Monani UR.
    J Neurosci; 2010 Sep 08; 30(36):12005-19. PubMed ID: 20826664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
    Goulet BB, Kothary R, Parks RJ.
    Curr Mol Med; 2013 Aug 08; 13(7):1160-74. PubMed ID: 23514457
    [Abstract] [Full Text] [Related]

  • 10. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL, Chen TH, Hsu YY, Cheng YH, Juang BT, Jong YJ.
    PLoS One; 2016 Aug 08; 11(4):e0154723. PubMed ID: 27124114
    [Abstract] [Full Text] [Related]

  • 11. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice.
    Mole AJ, Bell S, Thomson AK, Dissanayake KN, Ribchester RR, Murray LM.
    J Anat; 2020 Aug 08; 237(2):263-274. PubMed ID: 32311115
    [Abstract] [Full Text] [Related]

  • 12. Reduced P53 levels ameliorate neuromuscular junction loss without affecting motor neuron pathology in a mouse model of spinal muscular atrophy.
    Courtney NL, Mole AJ, Thomson AK, Murray LM.
    Cell Death Dis; 2019 Jul 04; 10(7):515. PubMed ID: 31273192
    [Abstract] [Full Text] [Related]

  • 13. Interaction between alpha-COP and SMN ameliorates disease phenotype in a mouse model of spinal muscular atrophy.
    Custer SK, Astroski JW, Li HX, Androphy EJ.
    Biochem Biophys Res Commun; 2019 Jun 25; 514(2):530-537. PubMed ID: 31060774
    [Abstract] [Full Text] [Related]

  • 14. Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy.
    Lee AJ, Awano T, Park GH, Monani UR.
    PLoS One; 2012 Jun 25; 7(9):e46353. PubMed ID: 23029491
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy.
    Hunter G, Powis RA, Jones RA, Groen EJ, Shorrock HK, Lane FM, Zheng Y, Sherman DL, Brophy PJ, Gillingwater TH.
    Hum Mol Genet; 2016 Jul 01; 25(13):2853-2861. PubMed ID: 27170316
    [Abstract] [Full Text] [Related]

  • 18. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.
    Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, Landmesser LT, Monani UR.
    Hum Mol Genet; 2008 Aug 15; 17(16):2552-69. PubMed ID: 18492800
    [Abstract] [Full Text] [Related]

  • 19. Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.
    Dachs E, Hereu M, Piedrafita L, Casanovas A, Calderó J, Esquerda JE.
    J Neuropathol Exp Neurol; 2011 Jun 15; 70(6):444-61. PubMed ID: 21572339
    [Abstract] [Full Text] [Related]

  • 20. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
    de la Fuente S, Sansa A, Periyakaruppiah A, Garcera A, Soler RM.
    Mol Neurobiol; 2019 Jun 15; 56(6):4414-4427. PubMed ID: 30327977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.